A detailed history of Kelly Financial Services LLC transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Kelly Financial Services LLC holds 2,300 shares of NTLA stock, worth $51,865. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,300
Previous 2,300 -0.0%
Holding current value
$51,865
Previous $63,000 19.05%
% of portfolio
0.02%
Previous 0.03%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Jul 17, 2024

SELL
$132.37 - $176.78 $49 Million - $65.4 Million
-370,093 Reduced 99.38%
2,300 $309 Million
Q2 2021

Jul 17, 2024

BUY
$60.88 - $161.91 $22.5 Million - $59.9 Million
370,093 Added 16091.0%
372,393 $2.3 Million
Q1 2019

Jul 17, 2024

BUY
$12.79 - $17.62 $29,416 - $40,526
2,300 New
2,300 $39.3 Million

Others Institutions Holding NTLA

About Intellia Therapeutics, Inc.


  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $1.71B
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track Kelly Financial Services LLC Portfolio

Follow Kelly Financial Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kelly Financial Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kelly Financial Services LLC with notifications on news.